Zevra Therapeutics ZVRA
NASDAQ ZVRA
$10.97 -0.37 (-3.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Total Current Liabilities (2014 - 2026)

Updated

Zevra Therapeutics (ZVRA) posted Total Current Liabilities of $48.63 million for Q2 2026, up 68.7% from $28.83 million a year earlier and up 3.4% from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) Total Current Liabilities (2014 - 2026) Analysis & Trends

At the end of FY2025, Zevra Therapeutics' Total Current Liabilities came in at $39.28 million, up 15.3% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of 39.1% (FY2020 to FY2025).
  • In prior years, Zevra Therapeutics' Total Current Liabilities was $34.07 million in FY2024 (-53.8%), $73.72 million in FY2023 (+513.2%), $12.02 million in FY2022 (+184.2%) and $4.23 million in FY2021 (-43.9%).
  • The Q2 2026 figure stands as the highest quarterly Total Current Liabilities since Q4 2023.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last three quarters, with growth averaging 15.5% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q4 2023, with growth of 513.2%; the weakest was Q3 2021, with a decline of 94.8%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $47.03 million (Q1 2026), $39.28 million (Q4 2025) and $26.11 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 54.90 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 41.64 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -31.55 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.94 Bn
10 Zevra Therapeutics 672.94 Mn -139.77 Mn 38.18 Mn 48.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.63 Mn
Mar 31, 2026 47.03 Mn
Dec 31, 2025 39.28 Mn
Sep 30, 2025 26.11 Mn
Jun 30, 2025 28.83 Mn
Mar 31, 2025 26.98 Mn
Dec 31, 2024 34.07 Mn
Sep 30, 2024 34.48 Mn
Jun 30, 2024 30.45 Mn
Mar 31, 2024 29.91 Mn
Dec 31, 2023 73.72 Mn
Sep 30, 2023 21.71 Mn
Jun 30, 2023 18.25 Mn
Mar 31, 2023 15.62 Mn
Dec 31, 2022 12.02 Mn
Sep 30, 2022 8.43 Mn
Jun 30, 2022 7.16 Mn
Mar 31, 2022 2.95 Mn
Dec 31, 2021 4.23 Mn
Sep 30, 2021 3.70 Mn
API Access

Zevra Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ZVRA&period=max&api_key=YOUR_API_KEY